Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Filby

Interventional Cardiology Pinehurst, NC Medical Doctor

NPI 1093827206 CMS profile 536753

155 Memorial Dr, Pinehurst, NC 28374

Open in the dashboard

General payments

$442,022

583 records reported · program years 2019–2025

Research payments

$134

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$837,044 paid to institutions, not to them · program years 2020–2025

Through program year 2025, Steven Filby of Pinehurst, NC is reported in the CMS Open Payments database as having received $442,022 across 583 general payments and $134 in research payments paid to them. Separately, studies naming them as principal investigator received $837,044 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $123,775 110
2024 General $166,303 171
2023 General $80,276 126
2023 Research $134 1
2022 General $60,689 101
2021 General $6,077 43
2020 General $4,428 16
2019 General $473 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Filby
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Steven Filby were reported at $123,775. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Steven Filby Interventional Cardiology median Middle half National median
2019 $473 $1,097 $329–$3,048 $163
2020 $4,428 $473 $161–$1,480 $114
2021 $6,077 $677 $233–$1,827 $132
2022 $60,689 $978 $333–$2,724 $149
2023 $80,276 $1,136 $382–$2,986 $160
2024 $166,303 $1,181 $395–$3,326 $164
2025 $123,775 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $414,162 419 payments
  2. Medtronic, Inc. $14,432 58 payments
  3. Abbott Laboratories $5,737 40 payments
  4. Medtronic Vascular, Inc. $3,875 10 payments
  5. Abiomed $1,816 12 payments
  6. Cardiva Medical, Inc. $644 7 payments
  7. Atricure, Inc. $264 7 payments
  8. Amgen Inc. $256 4 payments
  9. Edwards Lifesciences Corporation $255 2 payments
  10. Janssen Pharmaceuticals, Inc $242 8 payments
  11. Other $338 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $366,144 135 payments
  2. Consulting Fee $30,423 17 payments
  3. Travel and Lodging $24,495 55 payments
  4. Food and Beverage $20,960 376 payments
Products named General payments · program years 2019–2025
  1. WATCHMAN Access System $314,568 220 payments
  2. WATCHMAN WATCHMAN Pro_IC $36,951 32 payments
  3. WATCHMAN FLX $29,838 90 payments
  4. VersaCross Access Solution $17,613 18 payments
  5. ONYX FRONTIER $7,874 19 payments
  6. Ultra ICE Plus $5,671 3 payments
  7. RESOLUTE ONYX $4,737 10 payments
  8. Resolute $3,642 4 payments
  9. WATCHMAN Pain Management $3,546 14 payments
  10. DRAGONFLY OPSTAR $2,588 2 payments
  11. Other $13,215 160 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Abiomed $134 1 payment

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$162,521

Medicare's payments for the services billed

Medicare patients

323

Average age 78

Services billed

945

130 women, 193 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Atrial fibrillation 75%
Arthritis 62%
Heart failure 59%
Chronic kidney disease 51%
Diabetes 46%
COPD 37%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VYNDAQEL
  • PFIZER INC. $19
$19 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

584 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record